Название документа

tablets Vestibo are shown in a disease and Menyer's syndrome, characterized by three main symptoms:

  • dizziness, sometimes is followed by nausea and vomiting;
  • decrease in hearing (relative deafness);
  • sonitus.

For symptomatic treatment of vestibular dizziness of various origin.

Structure

Active ingredient: betahistine;

1 tablet supports a betagistin of dihydrochloride of 24 mg;

Excipients: povidone, cellulose microcrystalline, lactose, silicon dioxide colloidal, krospovidon, stearic acid.

Contraindication

Hypersensitivity to or in any of medicament excipients. Pheochromocytoma.

Route of administration

Daily dose for adults makes 24-48 mg, evenly distributed for reception within a day.

Dose should be selected individually, depending on effect. Reduction of symptoms is sometimes observed only after two-three weeks of treatment. The best results are sometimes achieved at administration of medicament within several months. There are data that purpose of treatment at the beginning of a disease prevents its progressing and/or a hearing loss at late stages.

Feature of use

Pregnant

Betagistin should not be applied during pregnancy, except for cases of undoubted need. Children

it is not recommended by

to p.

to

Drivers

to

It is contraindicated.

to

Overdose

to

Knows several cases of overdose of drug. At some patients easy and moderate symptoms (nausea, drowsiness, an abdominal pain) after administration of medicament in a dose up to 640 mg were observed. Serious complications (spasms, cardiopulmonary complications) were observed at intended reception of the raised doses of a betagistin, especially in combination with overdose of other medicines.

Side effects

  • from digestive tract. nausea and dyspepsia.
  • from nervous system. Headache.

Interaction

As betagistin is a histamine analog, interaction of a betagistin with antihistaminic medicaments can theoretically affect efficiency of one of these drugs.

Storage conditions

to Store

in original packing at a temperature not above 25 °C.

to Store

in the places inaccessible for children.

Expiration date - 3 years.

Characteristics
Active ingredients Betagistin
Amount of active ingredient 24 mg
Applicant Teva
Code of automatic telephone exchange N07CA01 Betagistin
Interaction with food Later
Light sensitivity Not sensitive
Market status The branded generic
Origin Chemical
Prescription status According to the prescription
Primary packing blister
Producer AT BALKANFARMA DUPNITSYA
Quantity in packing 60 tablets (6 blisters on 10 pieces)
Release form tablets for internal use
Route of administration Oral
Sign Import
Storage temperature from 5 °C to 25 °C
Trade name Vestibo

Reviews Vestibo of the tab. of 24 mg No. 60

5 Rating 1 Reviews

Quality
Speed
Delivery
Performance
Price

Vestibo of the tab. of 24 mg No. 60

  • Product Code: 182866
  • In Stock

  • Ready to ship
  • $67.52


Related Products

Last Viewed

Модули для Opencart